Immunic (IMUX) Stock Chart & Stock Price History → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free IMUX Stock Alerts $1.28 +0.03 (+2.40%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immunic Stock Price Performance5 Day Performance+3.23%1 Month Performance-11.11%3 Month Performance-2.29%6 Month Performance+29.27%Year-To-Date Performance-14.67%1 Year Performance-26.44% Receive IMUX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe World’s Richest Man Blindsided by AIThese billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you.Get the full story here. IMUX Stock Chart for Tuesday, May, 14, 2024 IMUX Chart by TradingView Immunic Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$1.26$1.28+1.99%$1.32$1.24162,487 shs$115.30 million05/13/2024$1.27$1.26-1.18%$1.29$1.24120,657 shs$113.05 million05/10/2024$1.24$1.27+2.42%$1.28$1.22153,819 shs$114.40 million05/09/2024$1.27$1.24-2.36%$1.35$1.23197,274 shs$111.70 million05/08/2024$1.38$1.27-7.97%$1.39$1.27187,079 shs$114.40 million05/07/2024$1.34$1.38+2.99%$1.44$1.32284,631 shs$124.31 million Get the Latest News and Ratings for IMUX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$1.37$1.34-2.19%$1.38$1.33154,564 shs$120.71 million05/03/2024$1.33$1.37+3.01%$1.39$1.33112,220 shs$123.41 million05/02/2024$1.30$1.33+2.31%$1.34$1.26134,643 shs$119.81 million05/01/2024$1.26$1.30+3.17%$1.34$1.26127,491 shs$117.10 million04/30/2024$1.23$1.26+2.44%$1.30$1.23224,654 shs$113.50 million04/29/2024$1.22$1.23+0.82%$1.27$1.22170,551 shs$110.80 million04/26/2024$1.26$1.22-3.17%$1.28$1.19236,436 shs$109.90 million04/25/2024$1.24$1.26+1.61%$1.27$1.19244,880 shs$113.31 million04/24/2024$1.24$1.24$1.29$1.22129,677 shs$111.51 million04/23/2024$1.23$1.24+0.81%$1.31$1.23203,479 shs$111.51 million04/22/2024$1.18$1.23+4.24%$1.25$1.17165,401 shs$110.61 million04/19/2024$1.27$1.18-7.09%$1.31$1.18365,394 shs$106.12 million04/18/2024$1.21$1.27+4.96%$1.32$1.20280,208 shs$114.21 million04/17/2024$1.28$1.21-5.47%$1.29$1.21188,325 shs$108.82 million04/16/2024$1.31$1.28-2.29%$1.33$1.24270,960 shs$115.11 million04/15/2024$1.44$1.31-9.03%$1.43$1.27378,080 shs$117.81 million04/12/2024$1.40$1.44+2.86%$1.46$1.40417,016 shs$129.50 million04/11/2024$1.39$1.40+0.72%$1.42$1.33216,806 shs$125.90 million04/10/2024$1.29$1.39+7.75%$1.41$1.27318,154 shs$125.00 million04/09/2024$1.29$1.29$1.34$1.26219,615 shs$116.01 million04/08/2024$1.28$1.29+0.78%$1.31$1.25167,338 shs$116.01 million04/05/2024$1.23$1.28+4.07%$1.33$1.22486,271 shs$115.11 million04/04/2024$1.22$1.23+0.82%$1.26$1.19296,062 shs$110.61 million04/03/2024$1.22$1.22$1.26$1.17293,250 shs$109.72 million04/02/2024$1.36$1.22-10.29%$1.35$1.21346,518 shs$109.72 million04/01/2024$1.32$1.36+3.03%$1.39$1.29236,767 shs$122.31 million03/29/2024$1.32$1.32$1.34$1.30215,951 shs$118.71 million03/28/2024$1.30$1.32+1.54%$1.33$1.30215,110 shs$118.71 million03/27/2024$1.28$1.30+1.56%$1.32$1.26170,626 shs$116.91 million03/26/2024$1.30$1.28-1.54%$1.32$1.28268,001 shs$115.11 million03/25/2024$1.32$1.30-1.52%$1.34$1.30137,050 shs$116.91 million03/22/2024$1.34$1.32-1.49%$1.37$1.32197,934 shs$118.71 million03/21/2024$1.38$1.34-2.90%$1.42$1.34219,219 shs$120.51 million03/20/2024$1.32$1.38+4.55%$1.40$1.31240,692 shs$124.10 millionMy system predicted the BA collapse – now it’s issuing an AI warning (Ad)Even after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market...03/19/2024$1.31$1.32+0.76%$1.35$1.29411,550 shs$118.71 million03/18/2024$1.31$1.31$1.36$1.26461,847 shs$117.81 million03/15/2024$1.30$1.31+0.77%$1.38$1.302.73 million shs$117.81 million03/14/2024$1.33$1.30-2.26%$1.35$1.28328,039 shs$116.91 million03/13/2024$1.36$1.33-2.21%$1.45$1.33436,804 shs$119.61 million03/12/2024$1.43$1.36-4.90%$1.46$1.35465,799 shs$122.30 million03/11/2024$1.53$1.43-6.54%$1.56$1.43417,193 shs$128.60 million03/08/2024$1.46$1.53+4.79%$1.63$1.491.06 million shs$137.59 million03/07/2024$1.47$1.46-0.68%$1.51$1.43478,843 shs$131.30 million03/06/2024$1.50$1.47-2.00%$1.54$1.43542,025 shs$132.20 million03/05/2024$1.53$1.50-1.96%$1.57$1.49631,365 shs$134.90 million03/04/2024$1.45$1.53+5.52%$1.55$1.39903,804 shs$137.59 million03/01/2024$1.47$1.45-1.02%$1.55$1.42883,316 shs$65.51 million02/29/2024$1.40$1.47+4.64%$1.47$1.36653,047 shs$66.19 million02/28/2024$1.39$1.40+0.72%$1.47$1.38846,118 shs$63.25 million02/27/2024$1.28$1.39+8.59%$1.43$1.321.11 million shs$62.80 million02/26/2024$1.22$1.28+4.92%$1.34$1.22721,074 shs$57.83 million02/23/2024$1.22$1.22$1.26$1.20648,120 shs$55.12 million02/22/2024$1.28$1.22-4.69%$1.31$1.171.07 million shs$55.12 million02/21/2024$1.36$1.28-5.54%$1.36$1.26991,917 shs$57.83 million02/20/2024$1.26$1.36+7.54%$1.37$1.26791,682 shs$61.22 million02/19/2024$1.26$1.26$1.33$1.241.09 million shs$56.93 million02/16/2024$1.34$1.26-5.97%$1.33$1.241.09 million shs$56.93 million02/15/2024$1.31$1.34+2.29%$1.40$1.31877,495 shs$60.50 million02/14/2024$1.16$1.31+12.93%$1.37$1.171.71 million shs$59.15 million02/13/2024$1.23$1.16-5.69%$1.23$1.13930,565 shs$52.37 million Related Companies: Cartesian Therapeutics Stock Price Chart Abeona Therapeutics Stock Price Chart Vistagen Therapeutics Stock Price Chart Coya Therapeutics Stock Price Chart Karyopharm Therapeutics Stock Price Chart Cellectar Biosciences Stock Price Chart Nuvectis Pharma Stock Price Chart OptiNose Stock Price Chart Rezolute Stock Price Chart Relmada Therapeutics Stock Price Chart Receive IMUX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMUX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperCrypto Millionaire Says: “Buy This $11 AI Coin.”InvestorPlaceThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.